Avalo Therapeutics Inc
F:C6K
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avalo Therapeutics Inc
F:C6K
|
US |
|
B
|
Birkenstock Holding PLC
SWB:7PV
|
UK |
|
F
|
Fulton Financial Corp
F:FU5
|
US |
|
A
|
Advanced Micro Devices Inc
BMV:AMD
|
US |
|
H
|
Howmet Aerospace Inc
F:48Z
|
US |
|
Mitsui & Co Ltd
OTC:MITSF
|
JP |
|
Trade Desk Inc
NASDAQ:TTD
|
US |
|
Deutsche Bank AG
NYSE:DB
|
DE |
|
A
|
Asahi Group Holdings Ltd
DUS:ABW
|
JP |
|
P
|
Procter & Gamble Co
XMUN:PRG
|
US |
|
D
|
DXC Technology Co
F:2XT
|
US |
|
A
|
Air China Ltd
XBER:AD2
|
CN |
|
H
|
Hong Kong Exchanges and Clearing Ltd
XMUN:HK2C
|
HK |
|
G
|
Globant SA
LSE:0RIX
|
LU |
|
Schibsted ASA
OSE:SCHB
|
NO |
|
D
|
Darden Restaurants Inc
F:DDN
|
US |
Wall St Price Targets
C6K Price Targets Summary
Avalo Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
C6K is 6.732 EUR with a low forecast of 4.792 EUR and a high forecast of 8.791 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is C6K's stock price target?
Price Target
6.732
EUR
According to Wall Street analysts, the average 1-year price target for
C6K is 6.732 EUR with a low forecast of 4.792 EUR and a high forecast of 8.791 EUR.